[1] | Frostegard, J., 2013, Immune mechanisms in atherosclerosis, especially in diabetes type 2, Front Endocrinol. (Lausanne), 4, 162. |
[2] | De Paoli, F., Staels, B., and Chinetti-Gbaguidi, G., 7-7-2014, Macrophage Phenotypes and Their Modulation in Atherosclerosis, Circ.J., (ePub ahead of Print), |
[3] | McWhorter, F. Y., Wang, T., Nguyen, P., Chung, T., and Liu, W. F., 10-22-2013, Modulation of macrophage phenotype by cell shape, Proc.Natl.Acad.Sci U.S.A, 110, 17253-17258. |
[4] | Tabas, I., Tall, A., and Accili, D., 1-8-2010, The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression, Circ.Res, 106, 58-67. |
[5] | Hao, W. and Friedman, A., 2014, The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model, PLoS. One., 9, e90497. |
[6] | Westerterp, M., Bochem, A. E., Yvan-Charvet, L., Murphy, A. J., Wang, N., and Tall, A. R., 1-3-2014, ATP-binding cassette transporters, atherosclerosis, and inflammation, Circ.Res, 114, 157-170. |
[7] | Westerterp, M., Murphy, A. J., Wang, M., Pagler, T. A., Vengrenyuk, Y., Kappus, M. S., Gorman, D. J., Nagareddy, P. R., Zhu, X., Abramowicz, S., Parks, J. S., Welch, C., Fisher, E. A., Wang, N., Yvan-Charvet, L., and Tall, A. R., 5-24-2013, Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice, Circ.Res, 112, 1456-1465. |
[8] | Tanaka, N., Abe-Dohmae, S., Iwamoto, N., Fitzgerald, M. L., and Yokoyama, S., 2011, HMG-CoA reductase inhibitors enhance phagocytosis by upregulating ATP-binding cassette transporter A7, Atherosclerosis, 217, 407-414. |
[9] | Meurs, I., Calpe-Berdiel, L., Habets, K. L., Zhao, Y., Korporaal, S. J., Mommaas, A. M., Josselin, E., Hildebrand, R. B., Ye, D., Out, R., Kuiper, J., van Berkel, T. J., Chimini, G., and Van, Eck M., 2012, Effects of deletion of macrophage ABCA7 on lipid metabolism and the development of atherosclerosis in the presence and absence of ABCA1, PLoS.One., 7, e30984. |
[10] | Kakimoto, T., Kimata, H., Iwasaki, S., Fukunari, A., and Utsumi, H., 2013, Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4, J.Endocrinol., 216, 13-20. |
[11] | Carley, A. N. and Severson, D. L., 5-15-2005, Fatty acid metabolism is enhanced in type 2 diabetic hearts, Biochim. Biophys. Acta, 1734, 112-126. |
[12] | Zanchi, C., Locatelli, M., Benigni, A., Corna, D., Tomasoni, S., Rottoli, D., Gaspari, F., Remuzzi, G., and Zoja, C., 2013, Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitor, PLoS.One., 8, e70775. |
[13] | Stohr, R. and Federici, M., 8-15-2013, Insulin resistance and atherosclerosis: convergence between metabolic pathways and inflammatory nodes, Biochem.J., 454, 1-11. |
[14] | Spalenza, V., Girolami, F., Bevilacqua, C., Riondato, F., Rasero, R., Nebbia, C., Sacchi, P., and Martin, P., 2011, Identification of internal control genes for quantitative expression analysis by real-time PCR in bovine peripheral lymphocytes, Vet.J., 189, 278-283. |
[15] | Gholam, P. M., Flancbaum, L., Machan, J. T., Charney, D. A., and Kotler, D. P., 2007, Nonalcoholic fatty liver disease in severely obese subjects, Am.J.Gastroenterol., 102, 399-408. |
[16] | Ichihara, S., Yamada, Y., Liu, F., Murohara, T., Itoh, K., Yamamoto, M., and Ichihara, G., 2010, Ablation of the transcription factor Nrf2 promotes ischemia-induced neovascularization by enhancing the inflammatory response, Arterioscler. Thromb. Vasc. Biol., 30, 1553-1561. |
[17] | Olmos, Y., Valle, I., Borniquel, S., Tierrez, A., Soria, E., Lamas, S., and Monsalve, M., 5-22-2009, Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes, J.Biol.Chem., 284, 14476-14484. |
[18] | Das, S. K., Sharma, N. K., Hasstedt, S. J., Mondal, A. K., Ma, L., Langberg, K. A., and Elbein, S. C., 2011, An integrative genomics approach identifies activation of thioredoxin/thioredoxin reductase-1-mediated oxidative stress defense pathway and inhibition of angiogenesis in obese nondiabetic human subjects, J. Clin. Endocrinol. Metab, 96, E1308-E1313. |
[19] | Kyaw, T., Winship, A., Tay, C., Kanellakis, P., Hosseini, H., Cao, A., Li, P., Tipping, P., Bobik, A., and Toh, B. H., 3-5-2013, Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice, Circulation, 127, 1028-1039. |
[20] | Foster, G. A., Gower, R. M., Stanhope, K. L., Havel, P. J., Simon, S. I., and Armstrong, E. J., 8-20-2013, On-chip phenotypic analysis of inflammatory monocytes in atherogenesis and myocardial infarction, Proc.Natl.Acad.Sci U.S.A, 110, 13944-13949. |
[21] | Stulc, T., Svobodova, H., Krupickova, Z., Dolezalova, R., Marinov, I., and Ceska, R., 2014, Rosiglitazone influences the expression of leukocyte adhesion molecules and CD14 receptor in type 2 diabetes mellitus patients, Physiol Res, 63 Suppl 2, S293-S298. |
[22] | Cheraghi, N., Dai, H., and Raghuveer, G., 2012, Vitamin D deficiency is associated with atherosclerosis-promoting risk factor clustering but not vascular damage in children, Med Sci Monit, 18, CR687-CR692. |
[23] | Jawien, J., Toton-Zuranska, J., Kus, K., Pawlowska, M., Olszanecki, R., and Korbut, R., 2012, The effect of AVE 0991, nebivolol and doxycycline on inflammatory mediators in an apoE-knockout mouse model of atherosclerosis, Med Sci Monit, 18, BR389-BR393. |
[24] | Esch, T. and Stefano, G. B., 2002, Proinflammation: A common denominator or initiator of different pathophysiological disease processes, Medical Science Monitor, 8, 1-9. |
[25] | Shen, J., Yang, M., Ju, D., Jiang, H., Zheng, J. P., Xu, Z., and Li, L., 4-30-2010, Disruption of SM22 promotes inflammation after artery injury via nuclear factor kappaB activation, Circ.Res, 106, 1351-1362. |
[26] | Radons, J., Gabler, S., Wesche, H., Korherr, C., Hofmeister, R., and Falk, W., 5-10-2002, Identification of essential regions in the cytoplasmic tail of interleukin-1 receptor accessory protein critical for interleukin-1 signaling, J. Biol. Chem., 277, 16456-16463. |
[27] | Luiking, Y. C., Ten Have, G. A., Wolfe, R. R., and Deutz, N. E., 11-15-2012, Arginine de novo and nitric oxide production in disease states, Am. J. Physiol Endocrinol. Metab, 303, E1177-E1189. |
[28] | Zhao, J. F., Shyue, S. K., Lin, S. J., Wei, J., and Lee, T. S., 2014, Excess nitric oxide impairs LXR(alpha)-ABCA1- dependent cholesterol efflux in macrophage foam cells, J. Cell Physiol, 229, 117-125. |
[29] | Wang, F., Guo, X., Shen, X., Kream, R. M., Mantione, K. J., and Stefano, G. B., 2014, Vascular Dysfunction Associated with Type II Diabetes and Alzheimer's Disease: A Potential Etiological Linkage, Med Sci Monit Basic Res, 20, 118-129. |
[30] | Cho, Y. E., Basu, A., Dai, A., Heldak, M., and Makino, A., 11-15-2013, Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice, Am. J. Physiol Cell Physiol, 305, C1033-C1040. |
[31] | Tsuchiya, K., Westerterp, M., Murphy, A. J., Subramanian, V., Ferrante, A. W., Jr., Tall, A. R., and Accili, D., 3-29-2013, Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice, Circ.Res, 112, 992-1003. |
[32] | Senyuk, V., Zhang, Y., Liu, Y., Ming, M., Premanand, K., Zhou, L., Chen, P., Chen, J., Rowley, J. D., Nucifora, G., and Qian, Z., 4-2-2013, Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis, Proc. Natl. Acad. Sci U.S.A, 110, 5594-5599. |
[33] | Bekkering, S., Quintin, J., Joosten, L. A., van der Meer, J. W., Netea, M. G., and Riksen, N. P., 2014, Oxidized Low-Density Lipoprotein Induces Long-Term Proinflammatory Cytokine Production and Foam Cell Formation via Epigenetic Reprogramming of Monocytes, Arterioscler. Thromb. Vasc. Biol., 34, 1731-1738. |
[34] | Leite, D. F., Echevarria-Lima, J., Calixto, J. B., and Rumjanek, V. M., 3-1-2007, Multidrug resistance related protein (ABCC1) and its role on nitrite production by the murine macrophage cell line RAW 264.7, Biochem. Pharmacol., 73, 665-674. |
[35] | Jedlitschky, G., Greinacher, A., Kroemer, H. K., 4-1-2012, Transporters in human platelets: physiologic function and impact for pharmacotherapy, Blood, 119, 3394-402. |
[36] | Baarine, M., Andreoletti, P., Athias, A., Nury, T., Zarrouk, A., Ragot, K., Vejux, A., Riedinger, J. M., Kattan, Z., Bessede, G., Trompier, D., Savary, S., Cherkaoui-Malki, M., and Lizard, G., 6-28-2012, Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins, Neuroscience, 213, 1-18. |
[37] | Gewaltig, J., Kummer, M., Koella, C., Cathomas, G., and Biedermann, B. C., 2008, Requirements for CD8 T-cell migration into the human arterial wall, Hum. Pathol., 39, 1756-1762. |
[38] | Deiuliis, J., Shah, Z., Shah, N., Needleman, B., Mikami, D., Narula, V., Perry, K., Hazey, J., Kampfrath, T., Kollengode, M., Sun, Q., Satoskar, A. R., Lumeng, C., Moffatt-Bruce, S., and Rajagopalan, S., 2011, Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers, PLoS. One., 6, e16376. |